Lecap Asset Management Ltd. Invests $3.92 Million in Humana Inc. (NYSE:HUM)

Lecap Asset Management Ltd. purchased a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 14,827 shares of the insurance provider's stock, valued at approximately $3,923,000. Humana comprises 0.9% of Lecap Asset Management Ltd.'s portfolio, making the stock its 7th biggest position.

Other large investors also recently bought and sold shares of the company. LFA Lugano Financial Advisors SA grew its holdings in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the period. OFI Invest Asset Management acquired a new stake in Humana in the 4th quarter valued at approximately $33,000. Riverview Trust Co acquired a new position in Humana during the 1st quarter worth about $34,000. Garde Capital Inc. purchased a new position in Humana during the 1st quarter valued at about $36,000. Finally, Transce3nd LLC acquired a new position in Humana in the 4th quarter valued at about $38,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on HUM shares. Guggenheim initiated coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price objective for the company. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target for the company in a research report on Thursday, May 1st. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Thursday, May 1st. Truist Financial set a $280.00 price objective on Humana and gave the company a "hold" rating in a research note on Tuesday, June 17th. Finally, Barclays set a $268.00 target price on Humana and gave the stock an "equal weight" rating in a research note on Thursday, June 12th. Seventeen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $280.76.

Humana Price Performance

Shares of NYSE HUM opened at $238.61 on Wednesday. Humana Inc. has a twelve month low of $212.45 and a twelve month high of $406.46. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. The stock has a market cap of $28.80 billion, a P/E ratio of 16.87, a P/E/G ratio of 1.77 and a beta of 0.43. The stock has a 50 day moving average of $243.81 and a two-hundred day moving average of $260.20.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. During the same quarter in the previous year, the firm earned $7.23 earnings per share. The business's quarterly revenue was up 8.4% compared to the same quarter last year. On average, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.48%. Humana's dividend payout ratio is currently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.